Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early Biological Therapy Within 12 Months of Diagnosis Leads to Higher Transmural Healing Rates in Crohn's Disease.
Revés J, Fernandez-Clotet A, Ordás I, Buisson A, Bazoge M, Hordonneau C, Ellul P, D'Anastasi M, Elorza A, Aduna M, Rodríguez-Lago I, Lajas IS, Raimundo A, Bettencourt PJG, Freire G, Sousa P, Primitivo A, Delgado I, Rimola J, Torres J. Revés J, et al. Among authors: elorza a. Clin Gastroenterol Hepatol. 2024 Aug 30:S1542-3565(24)00769-9. doi: 10.1016/j.cgh.2024.07.034. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39209193
Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial.
Ginard D, Barreiro-de Acosta M, Nos P, Moraleja I, Muñoz Nuñez F, Aldeguer X, Echarri A, Villoria A, Riestra S, Boscá Watts MM, González-Lama Y, Royo V, Ferreiro-Iglesias R, Iborra M, Elorza A, Fernandez-Pordomingo A, Sans M; Becalcu study. Ginard D, et al. Among authors: elorza a. Dig Dis. 2024;42(6):600-609. doi: 10.1159/000540792. Epub 2024 Aug 22. Dig Dis. 2024. PMID: 39173598 Free PMC article. Clinical Trial.
Combination of granulocyte-monocyte apheresis and ustekinumab: Multicentre and retrospective study.
Rodríguez-Lago I, Herrera-deGuise C, Boscá-Watts M, Rodríguez C, Leo-Carnerero E, Íñiguez MC, Cañete F, Chacón S, Cuarán C, Elorza A, Guerra-Del-Río E, Iglesias E, Sánchez D, Barreiro-de Acosta M, Ginard D, Cabriada JL. Rodríguez-Lago I, et al. Among authors: elorza a. Gastroenterol Hepatol. 2024 Dec;47(10):502195. doi: 10.1016/j.gastrohep.2024.502195. Epub 2024 May 6. Gastroenterol Hepatol. 2024. PMID: 38710466 Free article. English, Spanish.
Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study.
Holvoet T, Truyens M, De Galan C, Peeters H, Gismero FM, Elorza A, Torres P, Vandermeulen L, Jauregui-Amezaga A, Ferreiro-Iglesias R, Zabana Y, Reverter LP, Geldof J, Lobatón T. Holvoet T, et al. Among authors: elorza a. J Clin Med. 2024 Jan 9;13(2):365. doi: 10.3390/jcm13020365. J Clin Med. 2024. PMID: 38256499 Free PMC article.
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study].
Geldof J, Truyens M, Hanssens M, Van Gucht E, Holvoet T, Elorza A, Bouillon V, Barros S, Martins V, Argyriou K, Potamianos S, Diculescu M, Stroie T, Bossuyt P, Moens A, Theodoraki E, Koutroubakis IE, Pedro J, Fernandes S, Nikolaou P, Karmiris K, Baert FJ, Ferreiro-Iglesias R, Peeters H, Claeys S, Casanova MJ, Eder P, Porter RJ, Arnott I, Karakan T, Mesonero F, Revés J, Van Dyck E, Jauregui-Amezaga A, Mañosa M, Rivière P, Marquez Mosquera L, Portela F, Pimentel R, Lobaton T. Geldof J, et al. Among authors: elorza a. J Crohns Colitis. 2024 Aug 14;18(8):1202-1214. doi: 10.1093/ecco-jcc/jjae011. J Crohns Colitis. 2024. PMID: 38243807
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, Gisbert JP, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: elorza a. Gastroenterol Hepatol. 2024 Aug-Sep;47(7):750-758. doi: 10.1016/j.gastrohep.2023.12.012. Epub 2024 Jan 12. Gastroenterol Hepatol. 2024. PMID: 38219960 English, Spanish.
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, Gisbert JP, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: elorza a. Gastroenterol Hepatol. 2024 Oct;47(8):821-833. doi: 10.1016/j.gastrohep.2023.11.004. Epub 2023 Nov 23. Gastroenterol Hepatol. 2024. PMID: 38007154 English, Spanish.
84 results